SELE and psoriasis: Although antibodies against E-selectin were initially found to block the recruitment of neutrophils and lymphocytes in animal models of skin inflammation, a multicenter, randomized, placebo-controlled trial in patients with psoriasis found that administration of CDP850 did not result in an improvement in PASI scores, neutrophil counts, or lymphocyte counts in the dermis (11).